Nurix Therapeutics, Inc. NRIX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s software and technology licenses, net?
- Nurix Therapeutics, Inc. (NRIX) reported software and technology licenses, net of $7.41M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Nurix Therapeutics, Inc.'s software and technology licenses, net increased by 31.7% year-over-year, from $5.63M to $7.41M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s software and technology licenses, net has grown at a 110.6% compound annual growth rate (CAGR), from $177K to $7.34M.